共 176 条
[1]
Kleinberg M(2005)Aspergillosis in the CLEAR outcomes trial: working toward a real-world clinical perspective Med Mycol 43 S289-S294
[2]
Brown JM(2004)Fungal infections in bone marrow transplant patients Curr Opin Infect Dis 17 347-352
[3]
Marr KA(2002)Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients Clin Infect Dis 34 909-917
[4]
Carter RA(2005)Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program Med Mycol 43 S49-58
[5]
Crippa F(2003)Infections in patients with hematological cancer: recent developments Hematology Am Soc Hematol Educ Prog 1 438-472
[6]
Wald A(2016)Liposomal Amphotericin B (AmBisome): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions Drugs 76 485-500
[7]
Corey L(2009)Amphotericin B: side effects and toxicity Rev Iberoam Micol 26 223-227
[8]
Morgan J(2003)Amphotericin B Systematic Review Study Group. A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations Clin Ther. 25 1295-1320
[9]
Wannemuehler KA(2013)Toxicokinetic and mechanistic basis for the safety and tolerability of liposomal amphotericin B Expert Opin Drug Saf 12 881-895
[10]
Marr KA(2018)The evaluation of frequency of nephrotoxicity caused by liposomal amphotericin B J Infect Chemother 24 725-728